An alternative perspective on the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12 item Scale (FACIT-Sp-12) in people newly diagnosed with advanced cancer
Journal of Psychosocial Oncology · 2025-11-18
Pociredir, a novel oral once-daily fetal hemoglobin inducer: Results from the Phase 1b pioneer study in adult participants with severe sickle cell disease and hydroxyurea intolerance or unresponsiveness
Blood · 2025-11-03 · 2 citations
PREDICTIVE BLOOD-BASED BIOMARKERS IN CERVICAL CANCER PATIENTS TREATED WITH PACLITAXEL-BASED CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB: RESULTS FROM GOG-0240
International Journal of Gynecological Cancer · 2025-11-01
Predictive biomarkers for chemotherapy plus bevacizumab in recurrent/metastatic cervical cancer: The NRG Oncology/GOG-0240 National Institutes of Health Cancer Moonshot
Gynecologic Oncology · 2025-09-01
Tracking Changes in B Cell Antibodies in Cervical Cancer Patients Treated with Chemoradiation and Immunotherapy on GOG 9929
International Journal of Radiation Oncology*Biology*Physics · 2025-09-01
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer
Gynecologic Oncology · 2025-07-22 · 11 citations
Single-cell analysis of ovarian myeloid cells identifies age-associated changes in macrophages and signaling dynamics
Biology of Reproduction · 2025-06-03 · 11 citations
A Phase 1b, Open-label, Multiple-Dose Study Evaluating Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Pociredir in Patients With Sickle Cell Disease (SCD): Trial Design
Journal of sickle cell disease. · 2025-06-01
Durable responses in ICI-refractory or acquired resistance: Phase 2 study of NP-G2-044 combined with anti-PD-1 therapy.
Journal of Clinical Oncology · 2025-05-28
Abstract B017: Phase 2 Study of NP-G2-044, a Novel Fascin Inhibitor, in Combination with Anti-PD-1 Therapy in Patients with Solid Tumors Resistant to Prior Anti-PD-1 Therapy
Cancer Immunology Research · 2025-02-23
Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trial
Journal of Psychosocial Oncology · 2025-01-15 · 2 citations
Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses
UNC Libraries · 2024-10-23
nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study
Gynecologic Oncology · 2024-10-09 · 1 citations
TP004/#1561 A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
International Journal of Gynecological Cancer · 2024-10-01 · 1 citations
Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure
JAMA Oncology · 2024-07-25 · 27 citations